These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 9671070)
1. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas. Bartsch D; Bastian D; Barth P; Schudy A; Nies C; Kisker O; Wagner HJ; Rothmund M Ann Surg; 1998 Jul; 228(1):79-86. PubMed ID: 9671070 [TBL] [Abstract][Full Text] [Related]
2. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720 [TBL] [Abstract][Full Text] [Related]
3. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts. Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110 [TBL] [Abstract][Full Text] [Related]
4. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography. Lee JG; Leung JW; Cotton PB; Layfield LJ; Mannon PJ Gastrointest Endosc; 1995 Oct; 42(4):317-20. PubMed ID: 8536899 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses. Villanueva A; Reyes G; Cuatrecasas M; Martínez A; Erill N; Lerma E; Farré A; Lluís F; Capellá G Gastroenterology; 1996 May; 110(5):1587-94. PubMed ID: 8613066 [TBL] [Abstract][Full Text] [Related]
7. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485 [TBL] [Abstract][Full Text] [Related]
8. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature. Paal E; Thompson LD; Przygodzki RM; Bratthauer GL; Heffess CS Mod Pathol; 1999 May; 12(5):518-28. PubMed ID: 10349991 [TBL] [Abstract][Full Text] [Related]
10. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters. Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455 [TBL] [Abstract][Full Text] [Related]
11. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA. Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909 [TBL] [Abstract][Full Text] [Related]
12. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas. Kondo H; Sugano K; Fukayama N; Hosokawa K; Ohkura H; Ohtsu A; Mukai K; Yoshida S Cancer; 1997 Mar; 79(5):900-5. PubMed ID: 9041151 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Z'graggen K; Rivera JA; Compton CC; Pins M; Werner J; Fernández-del Castillo C; Rattner DW; Lewandrowski KB; Rustgi AK; Warshaw AL Ann Surg; 1997 Oct; 226(4):491-8; discussion 498-500. PubMed ID: 9351717 [TBL] [Abstract][Full Text] [Related]
14. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Warshaw AL; Compton CC; Lewandrowski K; Cardenosa G; Mueller PR Ann Surg; 1990 Oct; 212(4):432-43; discussion 444-5. PubMed ID: 2171441 [TBL] [Abstract][Full Text] [Related]
15. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Schoedel KE; Finkelstein SD; Ohori NP Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481 [TBL] [Abstract][Full Text] [Related]
16. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas. Mueller J; Gansauge S; Mattfeldt T Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268 [TBL] [Abstract][Full Text] [Related]
17. K-ras gene point mutations and p21ras immunostaining in human ovarian tumors. Semczuk A; Postawski K; Przadka D; Rozynska K; Wrobel A; Korobowicz E Eur J Gynaecol Oncol; 2004; 25(4):484-8. PubMed ID: 15285310 [TBL] [Abstract][Full Text] [Related]
18. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131 [TBL] [Abstract][Full Text] [Related]
19. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice. Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537 [TBL] [Abstract][Full Text] [Related]
20. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas. Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]